Petros Pharmaceuticals, Inc. (PTPI)
Q2-CY2026Q1-CY2026Q4-CY2025Q3-CY2025Q2-CY2025Q1-CY2025Q4-CY2024Q3-CY2024Q2-CY2024Q1-CY2024Q4-CY2023Q3-CY2023Q2-CY2023Q1-CY2023Q4-CY2022Q3-CY2022Q2-CY2022Q1-CY2022Q4-CY2021Q3-CY2021Q2-CY2021Q1-CY2021Q4-CY2020Q3-CY2020Q2-CY2020Q1-CY2020Q4-CY2019Q3-CY2019Q2-CY2019Q1-CY2019Q4-CY2018Q3-CY2018Q2-CY2018Q1-CY2018Q4-CY2017Q3-CY2017Q2-CY2017Q1-CY2017Q4-CY2016Q3-CY2016Q2-CY2016Q1-CY2016Q4-CY2015Q3-CY2015Q2-CY2015Q1-CY2015Q4-CY2014Q3-CY2014Q2-CY2014
Balance Sheet Date2025-Dec-312025-Sep-302025-Jun-302025-Mar-312024-Dec-312024-Sep-302024-Jun-302024-Mar-312023-Dec-312023-Sep-302023-Jun-302023-Mar-312022-Dec-312022-Sep-302022-Jun-302022-Mar-312021-Dec-312021-Sep-302021-Jun-302021-Mar-31
Fiscal PeriodQ4-FY2025Q3-FY2025Q2-FY2025Q1-FY2025Q4-FY2024Q3-FY2024Q2-FY2024Q1-FY2024Q4-FY2023Q3-FY2023Q2-FY2023Q1-FY2023Q4-FY2022Q3-FY2022Q2-FY2022Q1-FY2022Q4-FY2021Q3-FY2021Q2-FY2021Q1-FY2021
Total Revenue53,280$67,014$88,849$47,790$725,403$1,576,366$1,421,471$1,388,806$227,589$1,674,657$1,994,011$2,517,972$798,101$(1,457,732$)4,186,516$2,465,169$(867,160$)2,145,169$2,457,649$4,075,606$2,929,289$3,464,695$1,373,564$1,791,921$
QoQ%(20.49%)(24.58%)85.92%(93.41%)(53.98%)10.90%2.35%510.23%(86.41%)(16.02%)(20.81%)215.50%154.75%(134.82%)69.83%384.28%(140.42%)(12.72%)(39.70%)39.13%(15.45%)152.24%(23.35%)
YoY%(92.66%)(95.75%)(93.75%)(96.56%)218.73%(5.87%)(28.71%)(44.84%)(71.48%)214.88%(52.37%)2.14%192.04%(167.95%)70.35%(39.51%)(129.60%)(38.09%)78.93%127.44%
Cost Of Revenue0$0$0$0$264,754$287,005$329,110$331,831$749,986$408,475$513,857$550,742$881,332$286,525$649,220$472,340$243,728$319,158$393,294$643,386$1,741,297$981,903$539,231$784,035$
Gross Profit53,280$67,014$88,849$47,790$460,649$1,289,361$1,092,361$1,056,975$(522,397$)1,266,182$1,480,154$1,967,230$(83,231$)(1,744,257$)3,537,296$1,992,829$(1,110,888$)1,826,011$2,064,355$3,432,220$1,187,992$2,482,792$834,333$1,007,886$
Gross Margin100.00%100.00%100.00%100.00%63.50%81.79%76.85%76.11%(229.54%)75.61%74.23%78.13%(10.43%)119.66%84.49%80.84%128.11%85.12%84.00%84.21%40.56%71.66%60.74%56.25%
Operating Expenses391,486$990,737$1,800,778$1,458,349$577,554$1,197,359$1,349,103$1,502,926$4,516,221$6,072,823$3,942,962$3,276,527$4,017,881$11,927,761$5,198,716$2,474,027$6,862,312$5,422,628$6,345,047$5,629,727$5,505,977$4,819,213$5,852,641$6,617,210$
Operating Income(391,486$)(990,737$)(1,800,778$)(1,458,349$)(577,554$)(1,197,359$)(1,349,103$)(1,502,926$)(5,038,618$)(4,806,641$)(2,462,808$)(1,309,297$)(4,101,112$)(13,672,018$)(1,661,420$)(481,198$)(7,973,200$)(3,596,617$)(4,280,692$)(2,197,507$)(4,317,985$)(2,336,421$)(5,018,308$)(5,609,324$)
Operating Margin(734.77%)(1,478.40%)(2,026.79%)(3,051.58%)(79.62%)(75.96%)(94.91%)(108.22%)(2,213.91%)(287.02%)(123.51%)(52.00%)(513.86%)937.90%(39.69%)(19.52%)919.46%(167.66%)(174.18%)(53.92%)(147.41%)(67.44%)(365.35%)(313.03%)
Interest Income24,741$75,817$119,391$151,819$227,589$168,481$52,924$66,317$
Interest Expenses0$0$0$0$0$0$0$0$0$0$0$0$
Income Before Tax(336,506$)(922,723$)(2,041,272$)(1,199,541$)(552,813$)(919,541$)384,288$382,893$318,150$(4,549,508$)(2,546,683$)(1,385,147$)(4,231,861$)(13,819,695$)(1,811,792$)(174,224$)(8,194,987$)(1,694,553$)(2,106,217$)3,009,081$(6,815,070$)(3,306,506$)(5,778,152$)(6,113,190$)
Tax Expenses10,501$2,345$6,700$(1,377,098$)(6,143$)(13,781$)(29,971$)
Net Income(336,506$)(922,723$)5,432,846$(2,260,022$)(9,273,440$)(2,220,661$)(662,026$)(2,162,663$)318,150$(4,549,508$)(2,546,683$)(1,385,147$)(4,221,360$)(13,830,197$)(1,811,792$)(174,224$)(8,185,942$)(1,696,898$)(2,112,917$)3,009,081$(5,437,972$)(3,300,363$)(5,764,371$)(6,083,219$)
Profit Margin(631.58%)(1,376.91%)6,114.70%(4,729.07%)(1,278.39%)(140.87%)(46.57%)(155.72%)139.79%(271.67%)(127.72%)(55.01%)(528.93%)948.75%(43.28%)(7.07%)943.99%(79.10%)(85.97%)73.83%(185.64%)(95.26%)(419.67%)(339.48%)
TTM744.78%(755.97%)(341.26%)(382.29%)(280.10%)(102.45%)(149.73%)(169.17%)(127.27%)(181.86%)(570.65%)(351.51%)(334.40%)(554.73%)(149.68%)(196.26%)(115.05%)(53.75%)(60.66%)(97.05%)(215.35%)
Earnings to Minority1,515,141$3,026,054$2,072,893$5,864,281$4,158,133$1,493,078$(1$)
Earnings to Common Shareholders(336,506$)(922,723$)5,432,846$(2,260,022$)(10,788,581$)(5,246,715$)(2,734,919$)(8,026,944$)(3,839,983$)(6,042,586$)(2,546,683$)(1,385,147$)(4,221,360$)(13,830,196$)(1,811,792$)(174,224$)(8,185,942$)(1,696,898$)(2,112,917$)3,009,081$(5,437,972$)(3,300,363$)(5,764,371$)(6,083,219$)
QoQ%63.53%(116.98%)340.39%79.05%(105.63%)(91.84%)65.93%(109.04%)36.45%(137.27%)(83.86%)67.19%69.48%(663.34%)(939.92%)97.87%(382.41%)19.69%(170.22%)155.34%(64.77%)42.75%5.24%
YoY%96.88%82.41%298.65%71.85%(180.95%)13.17%(7.39%)(479.50%)9.03%56.31%(40.56%)(695.04%)48.43%(715.03%)14.25%(105.79%)(50.53%)48.59%63.35%149.47%
Earnings Per Share, Basic(0.01$)(0.02$)0.21$(1.95$)(26.63$)(13.34$)(9.25$)(42.19$)(1.61$)(2.85$)(1.20$)(0.66$)(2.03$)(6.69$)(0.88$)(0.08$)0.33$(0.17$)(0.22$)0.31$(0.57$)(0.96$)(1.68$)(1.23$)
Earnings Per Share, Diluted(0.01$)(0.02$)0.21$(1.95$)(26.63$)(13.34$)(9.25$)(42.19$)(1.61$)(2.85$)(1.20$)(0.66$)(2.03$)(6.69$)(0.88$)(0.08$)0.33$(0.17$)(0.22$)0.31$(0.57$)(0.96$)(1.68$)(1.23$)
Unlevered FCF Per Share, Basic(0.02$)(0.03$)(0.12$)(1.43$)2.37$(1.96$)(5.63$)(5.96$)(0.95$)(1.91$)(0.27$)(0.36$)(0.76$)(0.85$)(2.03$)(2.55$)0.33$(0.12$)(0.19$)(0.05$)(0.47$)(0.78$)(1.67$)(0.48$)
Unlevered FCF Per Share, Diluted(0.02$)(0.03$)(0.12$)(1.43$)2.37$(1.96$)(5.63$)(5.96$)(0.95$)(1.91$)(0.27$)(0.36$)(0.76$)(0.85$)(2.03$)(2.55$)0.33$(0.12$)(0.19$)(0.05$)(0.47$)(0.78$)(1.67$)(0.48$)
Average Shares, Basic42,892,65242,284,50225,922,5031,161,791405,174393,192295,524190,2782,378,1692,119,6202,117,5812,088,6982,075,4242,068,4722,068,4722,068,472-25,026,0869,826,5999,802,3099,753,0869,544,0163,434,5513,434,5514,949,610
Average Shares, Diluted42,892,65242,284,50225,922,5031,161,791405,174393,192295,524190,2782,378,1692,119,6202,117,5812,088,6982,075,4242,068,4722,068,4722,068,472-25,027,6869,826,5999,802,3099,754,6869,544,0163,434,5513,434,5514,949,610
EBIT(336,506$)(922,723$)(2,041,272$)(1,199,541$)(552,813$)(919,541$)384,288$382,893$318,150$(4,549,508$)(2,546,683$)(1,385,147$)(4,231,861$)(13,819,695$)(1,811,792$)(174,224$)(8,194,987$)(1,694,553$)(2,106,217$)3,009,081$(6,815,070$)(3,306,506$)(5,778,152$)(6,113,190$)
EBITDA(336,506$)(922,723$)(2,041,272$)(1,199,541$)103,280$(180,092$)1,102,126$1,100,732$1,120,732$(3,722,713$)(1,719,888$)(558,352$)(3,315,587$)(12,258,825$)(250,922$)1,386,646$(6,503,483$)34,276$(377,389$)4,737,910$(5,138,716$)(1,645,144$)(4,116,792$)(4,451,828$)